CRMD vs. INOD
CRMD (CorMedix Inc.) and INOD (Innodata Inc.) are both stocks. CRMD operates in Biotechnology (Healthcare), while INOD operates in Information Technology Services (Technology). Over the past 10 years, CRMD returned -1.91%/yr vs 45.64%/yr for INOD. At a 0.11 correlation, their price movements are largely independent.
Performance
CRMD vs. INOD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRMD achieves a -24.85% return, which is significantly lower than INOD's 98.04% return. Over the past 10 years, CRMD has underperformed INOD with an annualized return of -1.91%, while INOD has yielded a comparatively higher 45.64% annualized return.
CRMD
- 1D
- -2.46%
- 1M
- 16.53%
- YTD
- -24.85%
- 6M
- -23.93%
- 1Y
- -41.18%
- 3Y*
- 15.11%
- 5Y*
- 1.21%
- 10Y*
- -1.91%
INOD
- 1D
- -4.23%
- 1M
- 12.17%
- YTD
- 98.04%
- 6M
- 92.56%
- 1Y
- 137.86%
- 3Y*
- 114.32%
- 5Y*
- 69.37%
- 10Y*
- 45.64%
CRMD vs. INOD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | -24.85% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 2.06% | 12.87% | 158.00% | -67.32% |
INOD Innodata Inc. | 98.04% | 28.92% | 385.50% | 174.54% | -49.92% | 11.70% | 364.91% | -24.00% | 10.29% | -44.49% |
Correlation
The correlation between CRMD and INOD is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since May 13, 2010 | 0.11 |
The correlation between CRMD and INOD shifts across timeframes, from 0.11 (all time) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CRMD:
$812.69M
INOD:
$3.59B
CRMD:
$2.10
INOD:
$1.11
CRMD:
4.16
INOD:
90.91
CRMD:
1.88
INOD:
12.60
CRMD:
1.86
INOD:
28.00
CRMD:
$400.05M
INOD:
$283.42M
CRMD:
$343.39M
INOD:
$76.88M
CRMD:
$207.97M
INOD:
$37.35M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRMD vs. INOD — Risk / Return Rank
CRMD
INOD
CRMD vs. INOD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and Innodata Inc. (INOD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRMD | INOD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.74 | ||
| Sortino ratioReturn per unit of downside risk | -3.20 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.31 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.66 | 2.20 | -2.86 |
| Martin ratioReturn relative to average drawdown | -0.97 | 3.97 | -4.94 |
Loading charts...
Drawdowns
CRMD vs. INOD - Drawdown Comparison
The maximum CRMD drawdown since its inception was -98.28%, roughly equal to the maximum INOD drawdown of -95.47%. Use the drawdown chart below to compare losses from any high point for CRMD and INOD.
Loading charts...
Drawdown Indicators
| CRMD | INOD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -95.47% | -2.81% |
Max Drawdown (1Y)Largest decline over 1 year | -62.26% | -63.03% | +0.77% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -63.03% | +0.77% |
Max Drawdown (5Y)Largest decline over 5 years | -66.91% | -74.44% | +7.53% |
Max Drawdown (10Y)Largest decline over 10 years | -94.77% | -74.44% | -20.33% |
Current DrawdownCurrent decline from peak | -82.29% | -16.95% | -65.34% |
Average DrawdownAverage peak-to-trough decline | -77.55% | -60.07% | -17.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.56% | 34.83% | +7.73% |
Volatility
CRMD vs. INOD - Volatility Comparison
The current volatility for CorMedix Inc. (CRMD) is 12.12%, while Innodata Inc. (INOD) has a volatility of 32.31%. This indicates that CRMD experiences smaller price fluctuations and is considered to be less risky than INOD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRMD | INOD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.12% | 32.31% | -20.19% |
Volatility (6M)Calculated over the trailing 6-month period | 51.58% | 89.40% | -37.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.31% | 122.08% | -53.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.11% | 106.74% | -29.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.70% | 89.36% | +2.34% |
Dividends
CRMD vs. INOD - Dividend Comparison
Neither CRMD nor INOD has paid dividends to shareholders.
Financials
CRMD vs. INOD - Financials Comparison
This section allows you to compare key financial metrics between CorMedix Inc. and Innodata Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRMD vs. INOD - Profitability Comparison
CRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.
INOD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Innodata Inc. reported a gross profit of 0.00 and revenue of 90.10M. Therefore, the gross margin over that period was 0.0%.
CRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.
INOD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Innodata Inc. reported an operating income of 0.00 and revenue of 90.10M, resulting in an operating margin of 0.0%.
CRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.
INOD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Innodata Inc. reported a net income of 14.90M and revenue of 90.10M, resulting in a net margin of 16.5%.
Frequently Asked Questions
CRMD and INOD have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INOD has higher volatility (32.31%) compared to CRMD (12.12%). In terms of maximum drawdown, CRMD dropped -98.28% vs INOD's -95.47%.
INOD currently has the higher Sharpe Ratio (1.14 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRMD and INOD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer